Steven Lehrer

2.7k total citations
127 papers, 1.8k citations indexed

About

Steven Lehrer is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Steven Lehrer has authored 127 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 30 papers in Molecular Biology and 23 papers in Genetics. Recurrent topics in Steven Lehrer's work include Estrogen and related hormone effects (14 papers), Cancer Risks and Factors (12 papers) and Prostate Cancer Treatment and Research (11 papers). Steven Lehrer is often cited by papers focused on Estrogen and related hormone effects (14 papers), Cancer Risks and Factors (12 papers) and Prostate Cancer Treatment and Research (11 papers). Steven Lehrer collaborates with scholars based in United States, United Kingdom and Switzerland. Steven Lehrer's co-authors include Peter H. Rheinstein, Beth S. Schachter, Kenneth E. Rosenzweig, Richard G. Stock, Nelson N. Stone, Sheryl Green, Michael J. Droller, Edward J. Diamond, William D. Bloomer and Tamara Kalir and has published in prestigious journals such as The Lancet, Nucleic Acids Research and SHILAP Revista de lepidopterología.

In The Last Decade

Steven Lehrer

122 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven Lehrer United States 25 480 479 324 268 225 127 1.8k
Sandra L. Grimm United States 23 796 1.7× 476 1.0× 537 1.7× 188 0.7× 156 0.7× 75 1.7k
Zuoheng Wang United States 27 659 1.4× 641 1.3× 248 0.8× 488 1.8× 182 0.8× 90 2.3k
М. И. Воевода Russia 18 587 1.2× 742 1.5× 199 0.6× 124 0.5× 194 0.9× 277 2.5k
Yao Fan China 18 1.0k 2.1× 313 0.7× 262 0.8× 97 0.4× 148 0.7× 39 1.9k
Laurent Essioux Switzerland 18 600 1.3× 672 1.4× 169 0.5× 83 0.3× 249 1.1× 32 1.7k
Lorraine K. Miller United States 19 443 0.9× 249 0.5× 266 0.8× 237 0.9× 496 2.2× 38 1.7k
Jocelyn D. Glazier United Kingdom 35 861 1.8× 324 0.7× 246 0.8× 358 1.3× 140 0.6× 120 4.0k
Maritha J. Kotze South Africa 29 835 1.7× 597 1.2× 199 0.6× 81 0.3× 418 1.9× 185 3.1k
Brendan J. Keating United States 28 909 1.9× 823 1.7× 116 0.4× 107 0.4× 182 0.8× 102 2.8k
Imogen R. Coe Canada 28 872 1.8× 234 0.5× 461 1.4× 76 0.3× 88 0.4× 60 2.9k

Countries citing papers authored by Steven Lehrer

Since Specialization
Citations

This map shows the geographic impact of Steven Lehrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Lehrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Lehrer more than expected).

Fields of papers citing papers by Steven Lehrer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Lehrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Lehrer. The network helps show where Steven Lehrer may publish in the future.

Co-authorship network of co-authors of Steven Lehrer

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Lehrer. A scholar is included among the top collaborators of Steven Lehrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Lehrer. Steven Lehrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lehrer, Steven & Peter H. Rheinstein. (2025). Klebsiella pneumoniae infection increases risk of Alzheimer's disease in the UK Biobank cohort. Psychogeriatrics. 25(2). e70013–e70013.
2.
Lehrer, Steven & Peter H. Rheinstein. (2025). Re: Association of immunoglobulin E levels with glioma risk and survival. JNCI Journal of the National Cancer Institute. 117(3). 565–566. 1 indexed citations
3.
Lehrer, Steven & Peter H. Rheinstein. (2024). Salbutamol, a Short Acting Beta-2 Agonist, Reduces Risk and Improves Prognosis of Prostate Cancer. American Journal of Clinical Oncology. 47(12). 591–594. 3 indexed citations
4.
Lehrer, Steven & Peter H. Rheinstein. (2023). RORB, an Alzheimer’s disease susceptibility gene, is associated with viral encephalitis, an Alzheimer’s disease risk factor. Clinical Neurology and Neurosurgery. 233. 107984–107984. 3 indexed citations
5.
Lehrer, Steven & Peter H. Rheinstein. (2022). Alignment of human KAT2A (GCN5) histone acetyltransferase and SARS‐CoV‐2 Orf8 viral proteins. Chronic Diseases and Translational Medicine. 9(3). 263–265. 1 indexed citations
6.
Lehrer, Steven & Peter H. Rheinstein. (2022). Association of cannabis with chronic obstructive pulmonary disease and COVID‐19 infection. Chronic Diseases and Translational Medicine. 8(3). 238–241.
7.
Lehrer, Steven & Peter H. Rheinstein. (2022). Genome‐wide association study of dermatophytosis in the UK Biobank cohort. Journal of the European Academy of Dermatology and Venereology. 36(12). 2482–2487.
8.
Lehrer, Steven & Peter H. Rheinstein. (2022). Shingles vaccination reduces the risk of Parkinson's disease. Chronic Diseases and Translational Medicine. 9(1). 54–57. 3 indexed citations
9.
Lehrer, Steven & Peter H. Rheinstein. (2022). EARS2 significantly coexpresses with PALB2 in breast and pancreatic cancer. Cancer Treatment and Research Communications. 32. 100595–100595. 4 indexed citations
10.
Lehrer, Steven & Peter H. Rheinstein. (2022). α-synuclein enfolds tyrosine hydroxylase and dopamine ß-hydroxylase, potentially reducing dopamine and norepinephrine synthesis. Journal of Proteins and Proteomics. 13(2). 109–115. 3 indexed citations
11.
Lehrer, Steven & Peter H. Rheinstein. (2022). Cannabis smoking and age-related macular degeneration in the UK Biobank cohort. Journal Français d Ophtalmologie. 45(7). 756–761. 2 indexed citations
12.
Lehrer, Steven & Peter H. Rheinstein. (2021). BIN1 rs744373 SNP and COVID‑19 mortality. World Academy of Sciences Journal. 3(2). 7 indexed citations
13.
Lehrer, Steven & Peter H. Rheinstein. (2021). Common drugs, vitamins, nutritional supplements and COVID‑19 mortality. PubMed. 2(1). 3 indexed citations
14.
Lehrer, Steven & Peter H. Rheinstein. (2020). Statins combined with niacin reduce the risk of peripheral neuropathy. PubMed. 1(1). 4 indexed citations
15.
Lehrer, Steven & Peter H. Rheinstein. (2020). Alignment of Alzheimer's disease amyloid β‑peptide and klotho. World Academy of Sciences Journal. 2(6). 1–1. 20 indexed citations
16.
Lehrer, Steven, Peter H. Rheinstein, & Kenneth E. Rosenzweig. (2018). Loss of MycBP may be associated with the improved survival in 1P co-deletion of lower grade glioma patients. Clinical Neurology and Neurosurgery. 172. 112–115. 6 indexed citations
17.
Lehrer, Steven, Peter H. Rheinstein, & Kenneth E. Rosenzweig. (2018). Allergy may confer better survival on patients with gliomas. Clinical Neurology and Neurosurgery. 177. 63–67. 16 indexed citations
18.
Lehrer, Steven, Sheryl Green, & Kenneth E. Rosenzweig. (2016). Reduced Ovarian Cancer Incidence in Women Exposed to Low Dose Ionizing Background Radiation or Radiation to the Ovaries after Treatment for Breast Cancer or Rectosigmoid Cancer.. PubMed. 17(6). 2979–82. 9 indexed citations
19.
Lehrer, Steven & Kenneth E. Rosenzweig. (2014). Cold Climate Is a Risk Factor for Thyroid Cancer. Clinical Thyroidology. 26(10). 273–276. 30 indexed citations
20.
Lehrer, Steven, Vincent J. LaBombardi, Sheryl Green, et al.. (2011). No circulating cytomegalovirus in five patients with glioblastoma multiforme.. PubMed. 31(3). 959–60. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sandra L. Grimm Breakdown of academic impact, for papers by Zuoheng Wang Breakdown of academic impact, for papers by М. И. Воевода Breakdown of academic impact, for papers by Yao Fan Breakdown of academic impact, for papers by Laurent Essioux Breakdown of academic impact, for papers by Lorraine K. Miller Breakdown of academic impact, for papers by Jocelyn D. Glazier Breakdown of academic impact, for papers by Maritha J. Kotze Breakdown of academic impact, for papers by Brendan J. Keating Breakdown of academic impact, for papers by Imogen R. Coe
Rankless by CCL
2026